ARCHIVES

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

This article is from The Cancer Letter archive.

Vol. 12 No. 24 | June 13, 1986

Download PDF Visit The Full Archive

Related Articles

Letters To the Editor: NCI director Broder responds To Kopans On Mammography

October 8, 1993

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

Harkin to Ask NCI For Accounting Of Antineoplaston Trials

July 2, 1993

NCI Cooperative Group, Cancer Center Trials Listed

June 29, 2007